The global Electrophoresis Reagent market was valued at USD 978.2 Million in 2019 and is projected to reach USD 1,497.7 Million by 2027, expanding at a CAGR of 5.5% during the forecast period. The demand for electrophoresis reagent is growing with the rise in activities across the medical and pharmaceutical field around the globe. The COVID 19 outbreak has fueled many research and development activities and hence the demand for electrophoresis reagent has surged. COVID-19 has positively impacted research and development activities across the medical, pharmaceutical and biochemistry activities and that has helped in the growth of the electrophoresis reagent market.
Almost every industry related to medicines, biochemistry research and development, and biological research uses electrophoresis reagents. Comparatively quick and accurate results are helping electrophoresis reagents to gain popularity. The industrial production activities for electrophoresis reagents have been growing considerably in the last few years due to rising demand fueled by growth in R&D across the medical, pharmaceuticals, and life sciences areas. Which increased transportation and production of electrophoresis reagents. Industries related to electrophoresis reagents are growing with a consistent pace. Electrophoresis reagents R&D activities are expected to rise at a good pace during the pandemic; however, these activities are expected to continue till mid-2021.
Companies involved in the development of electrophoresis reagent are focusing on finding new applications for electrophoresis reagent. Constant investment in R&D activities to develop less hazardous products are expected to create lucrative opportunities during the forecast period.
Widespread Use of DNA Fingerprinting
A laboratory technique called DNA finger printing is used in law & order departments for criminal investigation. Acquired DNA evidence from the crime scene is compared with the suspect’s DNA in this process. Electrophoresis is used to conduct the process. If evidence and the suspect’s DNA match, the law enforcement authorities have their culprit. The process has proven itself to be accurate and useful in detecting criminals and is being widely used. The growing use of DNA finger printing method is driving the electrophoresis reagents market.
Increasing number of infections, chronic diseases are boosting activities in medical and pharmaceutical fields, thus driving the demand for electrophoresis reagents. Asia Pacific region to witness substantial growth during forecast period in terms of demand for electrophoresis reagents. The boom in healthcare industry owing to the rapidly growing population in the region is prime factor driving the market growth.
By Products Segment
Agarose gel segment is dominating the market in gels segment due to its accuracy in results. Other gel sub segments are growing with a substantial pace. Polyacrylamide Gels gel segment is anticipated to grow at significant CAGR due to rising applications of these gels in electrophoresis process.
Ethidium bromide is dominant segment in electrophoresis reagents market dyes segment. Ethidium bromide is widely used, however in recent days it is facing a slight decline in demand given its hazardous nature. Many alternatives for conventional dyes are entering the market which may take hold of the electrophoresis reagent market dyes sub segment.
Tris-acetate-EDTA and Tris-borate-EDTA both buffers are most commonly used buffers in electrophoresis method. Tris-borate-EDTA buffer is expected to dominate the electrophoresis regents market buffers sub segment.
By Techniques Segment
Gel electrophoresis is anticipated to be dominant technique as it is comparatively easy to perform than other techniques. The results obtained from gel electrophoresis are more precise. Moreover capillary electrophoresis is more time consuming and hard to perform in comparison of gel electrophoresis technique.
By Applications Segment
Based on Applications, the market is bifurcated into Protein Analysis and DNA & RNA Analysis. The protein analysis segment accounted for the largest share of this market. The factors can be attributed to the increasing focus on proteomics research by pharmaceutical and biotechnology companies. Protein analysis is anticipated to continue its dominance over electrophoresis market due to growing research and development activities in medical and pharmaceutical industry.
By End users Segment
In terms of end-users, the electrophoresis market is divided into academic and research institutions, hospitals & diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Rise in the demand for the manufacture of drugs and vaccines has led to the adoption of electrophoresis processes in academic and research institutions, which is driving the electrophoresis reagents market.
The pharmaceutical and biotechnology companies segment is anticipated to expand at a significant pace during the forecast period. Rise in the demand for research studies and increase in the outsourcing of research by pharmaceutical companies drives the demand for pharmaceutical and biotechnology companies.
The market in the Asia Pacific is projected to grow at a CAGR of 5.9% during forecast period. The factors such as growing chronic diseases including diabetes, cancer and others have claimed the most lives in south east Asian countries is contributing to rising R&D in the medical and pharmaceutical industry. Considering this, the governments in Asia pacific region are investing more in development of new vaccines, drugs and medications. The North America region is dominating the global electrophoresis reagents market owing to the strong drug discovery research going on in this region backed by the adoption of advanced diagnostics technologies in the areas of healthcare. Moreover, the rising number of research projects in proteomic and genomic is anticipated to be key factor propelling the demand for electrophoresis reagents in North America. The Europe region is following the North America region in terms of demand for electrophoresis reagents due to stringent regulatory requirements enforced on pharmaceutical industry. The Latin America and Middle East & Africa is anticipated to grow at moderate CAGR during forecast period.
Some frequently asked quetions about this report!
Additional company profiles can be provided on request.
Yes, the report covers products of electrophoresis reagents such as gels (Agarose gel, Polyacrylamide Gel, Starch Gel, Others) dyes (Ethidium Bromide, Bromophenol Blue, SYBR Dyes, Other Dyes) buffers (Tris-acetate-EDTA, Tris-borate-EDTA, Other Buffers), and others.
According to this Growth Market Reports report, the market from Electrophoresis Reagents is likely to register a CAGR of 5.5% during forecast period 2020-2027, with an anticipated valuation of USD 1,497.7 million by the end of the 2027.
In addition to market size (in USD Million) and Company Market Share (in % for base year 2019), other data such Macro-economic factors, COVID-19 Impact on the electrophoresis reagents market is available in final report.
The Electrophoresis reagents Market is anticipated to grow significantly during forecast period due to rise in demand for drug innovation due to growing infections and diseases. Moreover, use of electrophoresis in law and order to detect the criminals is also rising.
Protein analysis and DNA& RNA analysis are the key applications driving the market growth.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The market is expected to witness consistent growth with slight increase in terms of demand during 2019-2020 owing to the positive impact of COVID-19 pandemic on the electrophoresis reagents market.
The base year considered for the global electrophoresis reagents market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.
Major Manufactures include Agilent Technologies, Inc., BioAtlas, Bio-Rad Laboratories, Inc., Cytiva, Harvard Bioscience, Inc., Lonza Group Ltd., Merck KGaA, QIAGEN, GmbH, SEBIA, Takara Bio Inc., Thermo Fisher Scientific Inc.
Some other reports from this category!